Virax Biolabs Group Ltd (NASDAQ:VRAX) currently has a daily average trading volume of 5.96M but it saw 2769687 shares traded in last market. With a market cap of 11.15M USD, the company’s current market price of $2.57 came rising about 1.98 while comparing to the previous closing price of $2.52. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.00 and as low as $0.60. In the recent trading on the day, stock has struck highest price mark of $2.25 while lowest mark touched by it was $2.8.
Taking a look at 20-day trading activity of Virax Biolabs Group Ltd (VRAX) gives us an average price of $1.83, while its current price level is -71.44% below from 52-week high level whereas it is 328.33% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.84 while that of 200 days or SMA-200 reads an average of $1.46. A closer look into the stock’s movement over the week reveals that its volatility is standing at 22.59% during that period while stretching the period over a month that decreases to 14.87%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 61.37 which implies that the stock is in neutral territory.
Over the week, VRAX’s stock price is moving 64.74% up while it is 29.15% when we observe its performance for the past one month. Year-to-date it is 76.03% up and over the past year, the stock is showing a downside performance of -11.99%.
Currently, Virax Biolabs Group Ltd’s total number of outstanding shares is 4.34M. Company’s return on investment (ROI) stands at -121.48% and return on equity (ROE) at -92.92%. Stock’s beta reads 1.93. Stock has a price to book (P/B) ratio of 1.23 while price to sale or P/S ratio amounts to 69.71. Its return on asset (ROA) is -88.04% on average.
